St Johns Center for Clinical Research
Ponte Vedra, Florida, United States
Research institute in St. Johns County, Florida
100 Whetstone Pl Suites 300 - 301, St. Augustine, FL 32086
About St Johns Center for Clinical Research
"We are a member site of ENCORE Research Group, a premier clinical research organization that has conducted more than 2,500 clinical trials over 20 years and has worldwide recognition for providing patients access to cutting edge medical research. If you have a medical issue and want a research solution, or if you are a healthy volunteer, come visit our center and learn more. One of our experts will be happy to evaluate you."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
7
Astellas Pharma Global Development, Inc.
2
Gilead Sciences
2
Affinivax, Inc.
1
Bayer
1
Eisai Inc.
1
Freenome Holdings Inc.
1
Iroko Pharmaceuticals, LLC
1
Next Science TM
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Valneva Austria GmbH
1
Clinical Trials at St Johns Center for Clinical Research
During the past decade, St Johns Center for Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 13 clinical trials were completed, i.e. on
average, 144.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
2007-05-01
2010-05-01
Terminated
661
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin
2012-07-01
2013-05-01
Completed
354
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
2013-10-29
2017-07-10
Completed
2,139
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "St Johns Center for Clinical Research" #1 sponsor was "Pfizer" with 7 trials, followed by "Astellas Pharma Global Development, Inc." with 2 trials
sponsored, "Gilead Sciences" with 2 trials sponsored, "Affinivax, Inc." with 1 trials sponsored and "Bayer"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St Johns Center for Clinical Research"
#1 collaborator was "Fleming Island Center for Clinical Research" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Jacksonville Center For Clinical Research" with 1 trials as a collaborator, "St. Johns Center for Clinical Research" with 1 trials as a collaborator and "TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at St Johns Center for Clinical Research
According to Clinical.Site data, the most researched conditions in "St Johns Center for Clinical Research" are
"Cardiovascular Disease" (3 trials), "Hot Flashes" (2 trials), "Hyperlipidemia" (2 trials), "Hypertension" (2 trials) and "Acne Vulgaris" (1 trials). Many other conditions were trialed in "St Johns Center for Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at St Johns Center for Clinical Research
Most popular intervention types in "St Johns Center for Clinical Research" are "Drug" (16 trials), "Biological" (3 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Darusentan" (2 trials), "Guanfacine" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "fezolinetant" (2 trials). Other intervention names were less common.
Clinical Trials Genders at St Johns Center for Clinical Research
The vast majority of trials in "St Johns Center for Clinical Research" are
17 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at St Johns Center for Clinical Research
Currently, there are NaN active trials in "St Johns Center for Clinical Research".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in St Johns Center for Clinical Research,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in St Johns Center for Clinical Research, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".